With other cultivated meat companies are collapsing, this one turned a profit | E2317

Summary

Jason Calacanis interviews Dr. Yuki Hanyu, CEO of IntegriCulture, a Japanese startup making cell-cultured protein and cosmetics. The conversation covers the state of cultivated meat (stuck in a stunt phase due to cost and scale), IntegriCulture's unique open-source origins and ecosystem, their pivot to cosmetics for revenue, and the regulatory landscape in Japan versus the US. They also discuss future market steps, the difficulty of competing with cheap commodity meats, and cultural differences in doing business.

• Cultivated meat industry is still in the stunt/niche phase, far from mainstream due to scale and unit economics.
• IntegriCulture originated as a DIY open-source movement and built an ecosystem of community, non-profit advocacy, and a for-profit company.
• The company uses a contract-manufacturing-like model and sells tools, materials, and eventually production capability to other startups.
• IntegriCulture achieved profitability by selling cell-cultured cosmetics ingredients (e.g., placenta cells) before its food products are market-ready.
• Japanese regulatory framework for cultivated meat is pending, with clearance possibly by end of summer or early autumn 2025.
• Cultivated meat faces cultural and political controversy, especially in the US, but the current scale is minuscule compared to traditional meat.
• Price parity for niche products like foie gras is closer, while commodity meats like chicken may take a decade or more.
• The founder stresses the importance of team building, trust-based business relationships, and having a clear vision to navigate the hype cycle.